ArticleScientific reports2026
A diffusion model conditioned on compound bioactivity profiles for generating high-content images.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High-content imaging (HCI) provides a rich snapshot of compound-induced phenotypic outcomes that augment our understanding of how compounds affect cellular systems. Generative imaging models for HCI provide a route towards anticipating the phenotypic outcomes of chemical perturbations in silico at unprecedented scale and speed. Here, we developed Profile-Diffusion (pDIFF), a generative method leveraging a profile-to-image latent diffusion model conditioned on in silico bioactivity profiles to generate high-content images displaying the cellular outcomes induced by compound treatment. We trained and evaluated a pDIFF model using high-content images from a Cell Painting assay profiling 3750 molecules (3375 training compounds and 375 held-out compounds) with corresponding in silico bioactivity profiles. Using the held-out set we demonstrate that pDIFF provides improved visual depictions of phenotypic responses of compounds that are structurally dissimilar to training compounds, compared to a baseline profile-to-image latent diffusion model trained on substructural molecular descriptors only. In a virtual hit expansion scenario, pDIFF yielded statistically significant improvement in expansion outcomes as measured by nearest-neighbor retrieval accuracy, compared to expansions based on compound structural representations, bioactivity profiles, and generative imaging models based only on substructural molecular descriptors, thus showcasing the potential of the methodology to speed up and improve the search for novel phenotypically active molecules.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.